Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 889

1.

Petals and Thorns in Programmed Death-Ligand 1 Testing: Is All Non-Small Cell Lung Cancer Diagnostic Material Suitable?

Bravaccini S, Bronte G.

Cancer Cytopathol. 2018 Sep 21. doi: 10.1002/cncy.22033. [Epub ahead of print] No abstract available.

PMID:
30239146
2.

Reply to Petals and Thorns in Programmed Death-Ligand 1 Testing: Is All Non-Small Cell Lung Cancer Diagnostic Material Suitable?

Russell-Goldman E, Sholl LM, Vivero M.

Cancer Cytopathol. 2018 Sep 21. doi: 10.1002/cncy.22032. [Epub ahead of print] No abstract available.

PMID:
30239144
3.

Use of a Low-Cost Telecytopathology Method for Remote Assessment of Thyroid FNAs.

Costa C, Pastorello RG, Mendonça A, Tamaro C, Morais C, Barbosa B, Ribeiro KB, Caivano A, Saieg MA.

Cancer Cytopathol. 2018 Sep 19. doi: 10.1002/cncy.22026. [Epub ahead of print]

PMID:
30230262
4.

Improved Diagnostic Precision of Urine Cytology by Implementation of The Paris System and the Use of Cell Blocks.

Chan E, Balassanian R, Tabatabai ZL, Lou H, Vohra P.

Cancer Cytopathol. 2018 Sep 11. doi: 10.1002/cncy.22034. [Epub ahead of print]

PMID:
30203925
5.

Molecular Genetic Alterations in Thyroid Transcription Factor 1-Negative Lung Adenocarcinoma in Cytology Specimens: A Subset With Aggressive Behavior and a Poor Prognosis.

Rodriguez EF, VandenBussche CJ, Chowsilpa S, Maleki Z.

Cancer Cytopathol. 2018 Sep 10. doi: 10.1002/cncy.22048. [Epub ahead of print]

PMID:
30199148
6.

Flow Immunophenotyping of Benign Lymph Nodes Sampled by FNA: Representative With Diagnostic Pitfalls.

Scott GD, Lau HD, Kurzer JH, Kong CS, Gratzinger DA.

Cancer Cytopathol. 2018 Sep 7. doi: 10.1002/cncy.22038. [Epub ahead of print]

PMID:
30194715
7.

Evaluation of Diagnostic Accuracy and a Practical Algorithmic Approach for the Diagnosis of Renal Masses by FNA.

Lau HD, Kong CS, Kao CS.

Cancer Cytopathol. 2018 Sep 7. doi: 10.1002/cncy.22037. [Epub ahead of print]

PMID:
30193011
8.

Ancillary studies in cytology: Secondary or necessary?

Clark DP.

Cancer Cytopathol. 2018 Aug;126 Suppl 8:584-589. doi: 10.1002/cncy.22011. Review.

PMID:
30156778
9.

Ancillary tests in the diagnosis of liver and pancreatic neoplasms.

Misdraji J, Centeno BA, Pitman MB.

Cancer Cytopathol. 2018 Aug;126 Suppl 8:672-690. doi: 10.1002/cncy.22009. Review.

PMID:
30156777
10.

Identification of infectious organisms in cytopathology: A review of ancillary diagnostic techniques.

Allison DB, Simner PJ, Ali SZ.

Cancer Cytopathol. 2018 Aug;126 Suppl 8:643-653. doi: 10.1002/cncy.22023. Review.

PMID:
30156776
11.

Ancillary molecular testing of indeterminate thyroid nodules.

Rossi ED, Larocca LM, Pantanowitz L.

Cancer Cytopathol. 2018 Aug;126 Suppl 8:654-671. doi: 10.1002/cncy.22012. Review.

PMID:
30156775
12.

Application of ancillary studies in soft tissue cytology using a pattern-based approach.

Chebib I, Jo VY.

Cancer Cytopathol. 2018 Aug;126 Suppl 8:691-710. doi: 10.1002/cncy.22030. Review.

PMID:
30156774
13.

Navigating the diverse array of ancillary markers available for cytology.

Faquin WC.

Cancer Cytopathol. 2018 Aug;126 Suppl 8:581-583. doi: 10.1002/cncy.22039. No abstract available.

PMID:
30156773
14.

A practical guide for ancillary studies in pulmonary cytologic specimens.

Auger M, Brimo F, Kanber Y, Fiset PO, Camilleri-Broet S.

Cancer Cytopathol. 2018 Aug;126 Suppl 8:599-614. doi: 10.1002/cncy.22028. Review.

PMID:
30156772
15.

Lymph node cytopathology: Essential ancillary studies as applied to lymphoproliferative neoplasms.

Jin M, Wakely PE Jr.

Cancer Cytopathol. 2018 Aug;126 Suppl 8:615-626. doi: 10.1002/cncy.22013. Review.

PMID:
30156771
16.

Ancillary studies in fine needle aspiration of the kidney.

Renshaw AA, Gould EW.

Cancer Cytopathol. 2018 Aug;126 Suppl 8:711-723. doi: 10.1002/cncy.22029. Review.

PMID:
30156770
17.

cancer of unknown primary: Ancillary testing of cytologic and small biopsy specimens in the era of targeted therapy.

Cowan ML, VandenBussche CJ.

Cancer Cytopathol. 2018 Aug;126 Suppl 8:724-737. doi: 10.1002/cncy.22014. Review.

PMID:
30156769
18.

Ancillary studies in pleural, pericardial, and peritoneal effusion cytology.

Sundling KE, Cibas ES.

Cancer Cytopathol. 2018 Aug;126 Suppl 8:590-598. doi: 10.1002/cncy.22021. Review.

PMID:
30156768
19.

Ancillary testing in salivary gland cytology: A practical guide.

Jo VY, Krane JF.

Cancer Cytopathol. 2018 Aug;126 Suppl 8:627-642. doi: 10.1002/cncy.22010. Review.

PMID:
30156767
20.

Pre-analytic error: A significant patient safety risk.

Heher YK, Chen Y, VanderLaan PA.

Cancer Cytopathol. 2018 Aug;126 Suppl 8:738-744. doi: 10.1002/cncy.22019. Review.

PMID:
30156766

Supplemental Content

Loading ...
Support Center